A systematic review of adherence to cardiovascular medications in resource-limited settings

Journal of General Internal Medicine

Volumn 26, Issue 12, 2011, Pages 1479-1491

  Bowry, Ashna D K ^a,b   Shrank, William H ^a   Lee, Joy L ^a   Stedman, Margaret ^a   Choudhry, Niteesh K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

cardiovascular disease; cardiovascular medications; cardiovascular risk reduction; compliance

Indexed keywords

CARDIOVASCULAR AGENT;

AGE DISTRIBUTION; ATTITUDE TO HEALTH; CHRONICITY; COMORBIDITY; DEVELOPING COUNTRY; DRUG COST; DRUG SAFETY; FAMILY; HEALTH CARE ACCESS; HUMAN; MEDICAL LITERATURE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PEER REVIEW; REVIEW; SELF REPORT; SEX DIFFERENCE; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT REFUSAL; URBAN RURAL DIFFERENCE;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DEVELOPING COUNTRIES; HEALTH RESOURCES; HUMANS; MEDICATION ADHERENCE;

EID: 83655163854     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-011-1825-3     Document Type: Review

References (100)

1. WHO. Adherence to Long-term Therapies: Evidence for action. World Health Organisation 2003.
2. NK Choudhry 2010 Improving the pathway from cardiovascular medication prescribing to longer-term adherence: new results about old issues Circ Cardiovasc Qual Outcomes 3 223 5 20484200 10.1161/CIRCOUTCOMES.110.957142
3. NK Choudhry S Setoguchi R Levin WC Winkelmayer WH Shrank 2008 Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients Pharmacoepidemiol Drug Saf 17 1189 96 18956426 10.1002/pds.1671
4. NK Choudhry WC Winkelmayer 2008 Medication adherence after myocardial infarction: a long way left to go J Gen Intern Med 23 216 8 18183470 10.1007/s11606-007-0478-8
5. DR Bangsberg FM Hecht ED Charlebois, et al. 2000 Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population AIDS 14 357 66 10770537 10.1097/00002030-200003100-00008 1:CAS:528:DC%2BD3cXis1egu7s%3D
6. EJ Mills JB Nachega I Buchan, et al. 2006 Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis JAMA 296 679 90 16896111 10.1001/jama.296.6.679 1:CAS:528:DC%2BD28XotFagtbY%3D
7. International Monetary Fund. World economic and financial surveys: List of emerging and developing economies; 2009.
8. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses.
9. West S, King V, Carey ST, et al. Systems to Rate the Strength Of Scientific Evidence: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services; 2002 April 2002.
10. AR Jadad RA Moore D Carroll, et al. 1996 Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 12 8721797 10.1016/0197-2456(95)00134-4 1:STN:280:DyaK28zgvVCmug%3D%3D
11. Jaynes ET. Confidence intervals vs. Bayesian intervals. In: Harper WL, Hooker CA, eds. Foundations of probability theory, statistical inference, and statistical theories of science. Dordrecht: Reidel; 1976.
12. Stuart A, Ord JK. Kendall's Advanced Theory of Statistics. 6th ed. London: Arnold Publishers; 1994.
13. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 88 3802833 10.1016/0197-2456(86)90046-2 1:STN:280: DyaL2s7gsVamtA%3D%3D
14. JL Fleiss 1993 The statistical basis of meta-analysis Stat Methods Med Res 2 121 45 8261254 10.1177/096228029300200202 1:STN:280:DyaK2c%2FosVCktQ%3D%3D
15. JP Higgins SG Thompson 2002 Quantifying heterogeneity in a meta-analysis Stat Med 21 1539 58 12111919 10.1002/sim.1186
16. MR Akpa DI Agomuoh OJ Odia 2005 Drug compliance among hypertensive patients in Port Harcourt, Nigeria Niger J Med 14 55 7 15832644 1:STN:280:DC%2BD2M7pvV2mtA%3D%3D
17. A Almas A Hameed B Ahmed M Islam 2006 Compliance to antihypertensive therapy J Coll Physicians Surg Pak 16 23 6 16441983
18. OC Amira NU Okubadejo 2007 Frequency of complementary and alternative medicine utilization in hypertensive patients attending an urban tertiary care centre in Nigeria BMC Complement Altern Med 7 30 17903257 10.1186/1472-6882-7-30
19. A Ben Abdelaziz A Ben Othman O Mandhouj R Gaha Z Bouabid H Ghannem 2006 [Audit of management of arterial hypertension in primary health care in Sousse] Tunis Med 84 148 54 16755954
20. NE Bharucha T Kuruvilla 2003 Hypertension in the Parsi community of Bombay: a study on prevalence, awareness and compliance to treatment BMC Public Health 3 1 12513697 10.1186/1471-2458-3-1
21. P Bovet M Burnier G Madeleine B Waeber F Paccaud 2002 Monitoring one-year compliance to antihypertension medication in the Seychelles Bull World Health Organ 80 33 9 11884971
22. K Buabeng 2004 Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana J Pharm Pharm Sci 7 350 2
23. N Buchanan E Shuenyane S Mashigo P Mtangai B Unterhalter 1979 Factors influencing drug compliance in ambulatory Black urban patients S Afr Med J 55 368 73 432731 1:STN:280:DyaE1M7lvFynsQ%3D%3D
24. RA Castro JE Moncau LF Marcopito 2007 Hypertension prevalence in the city of Formiga, MG, Brazil Arq Bras Cardiol 88 334 9 17533476 10.1590/S0066- 782X2007000300013
25. W Chen X Huang J Zheng W Huang 2004 Survey on drug compliance of patients with hypertension in residents at Shangmeilin new community in Shenzhen Chin J Clin Rehabil 8 5790 1
26. EB Coelho 2005 Moyses Neto M, Palhares R, Cardoso MC, Geleilete TJ, Nobre F [Relationship between regular attendance to ambulatory appointments and blood pressure control among hypertensive patients] Arq Bras Cardiol 85 157 61 16200260
27. WA de Souza JC Yugar-Toledo G Bergsten-Mendes M Sabha H Moreno Jr 2007 Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension Am J Health Syst Pharm 64 1955 61 17823108 10.2146/ajhp060547
28. CR Dennison N Peer K Steyn NS Levitt MN Hill 2007 Determinants of hypertension care and control among peri-urban Black South Africans: the HiHi study Ethn Dis 17 484 91 17985502
29. AG Elzubier AA Husain IA Suleiman ZA Hamid 2000 Drug compliance among hypertensive patients in Kassala, eastern Sudan East Mediterr Health J 6 100 5 11370321 1:STN:280:DC%2BD3M3nsVCntw%3D%3D
30. L Feng J Lui Y Duan 2005 Medical order-obeying behavior in 164 patients with essential hypertension Chin J Clin Rehabil 9 150 1
31. GJ Fodor M Kotrec K Bacskai, et al. 2005 Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study J Hypertens 23 1261 6 15894903 10.1097/01.hjh.0000170390. 07321.ca 1:CAS:528:DC%2BD2MXktFynt7Y%3D
32. N Hadi N Rostami-Gooran 2004 Determinant factors of medication compliances in hypertensive patients of Shiraz, Iran Archives of Iranian Medicine 7 292 6
33. NB Hassan CI Hasanah K Foong, et al. 2006 Identification of psychosocial factors of noncompliance in hypertensive patients J Hum Hypertens 20 23 9 16177812 10.1038/sj.jhh.1001930 1:STN:280:DC%2BD2MnmvFKltw%3D%3D
34. P Hungerbuhler P Bovet C Shamlaye B Burnand B Waeber 1995 Compliance with medication among outpatients with uncontrolled hypertension in the Seychelles Bull World Health Organ 73 437 42 7554014 1:STN:280:DyaK28%2FktV2iuw%3D%3D
35. PP Joshi RG Salkar RF Heller 1996 Determinants of poor blood pressure control in urban hypertensives of central India J Hum Hypertens 10 299 303 8817403 1:STN:280:DyaK28vhsVektw%3D%3D
36. C Konin M Adoh I Coulibaly, et al. 2007 Black Africans' compliance to antihypertensive treatment Arch Mal Coeur Vaiss 100 630 4 17928765 1:STN:280:DC%2BD2sngsFGqtQ%3D%3D
37. EV Lambert K Steyn S Stender N Everage JM Fourie MN Hill 2006 Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting Ethn Dis 16 286 91 16599385
38. W Li X Jiang H Ma, et al. 2003 Awareness, treatment and control of hypertension in patients attending hospital clinics in China J Hypertens 21 1191 7 12777957 10.1097/00004872-200306000-00020
39. TO Lim BA Ngah 1991 The Mentakab Hypertension Study project. Part II-Why do hypertensives drop out of treatment? Singapore Med J 32 249 51 1776004 1:STN:280:DyaK387jt1Kjug%3D%3D
40. J Lu LM Li WH Cao SY Zhan YH Hu 2004 Postmarketing surveillance on Benazepril Zhonghua Liu Xing Bing Xue Za Zhi 25 412 6 15231167
41. DW Lunt PR Edwards K Steyn CJ Lombard GS Fehrsen 1998 Hypertension care at a Cape Town community health centre S Afr Med J 88 544 8 9638121 1:STN:280:DyaK1czgtF2lug%3D%3D
42. EE Maro J Lwakatare 1997 Medication compliance among Tanzanian hypertensives East Afr Med J 74 539 42 9487426 1:STN:280:DyaK1c7kvVCjtA%3D%3D
43. RA Marshall D Yach 1988 Management of hypertension in Mamre women S Afr Med J 74 346 8 3420483 1:STN:280:DyaL1czjslSjug%3D%3D
44. A Naddaf 2004 Lifestyle of hypertensive patients and their drug compliance Bulletin of Pharmaceutical Sciences 27 307 14
45. A Nugmanova G Pillai D Nugmanova D Kuter 2008 Improving the management of hypertension in Kazakhstan: Implications for improving clinical practice, patient behaviors, and health outcomes Global Public Health 3 214 31 19288372 10.1080/17441690701872664 1:STN:280:DC%2BD1M3gvF2ltw%3D%3D
46. K Peltzer 2004 Health beliefs and prescription medication compliance among diagnosed hypertension clinic attenders in a rural South African Hospital Curationis 27 15 23 15777026 1:STN:280:DC%2BD2M7ksFWntg%3D%3D
47. NN Qureshi J Hatcher N Chaturvedi TH Jafar 2007 Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial BMJ 335 1030 17991935 10.1136/bmj.39360.617986.AE
48. PK Roy SM Arif MR Alam FD Khan Q Ahmad SG Chowdhury 1990 Stroke in patients having inadequate or irregular antihypertensive therapy Bangladesh Med Res Counc Bull 16 52 7 2096811 1:STN:280:DyaK3M3msVOisQ%3D%3D
49. BL Salako FA Ajose E Lawani 2003 Blood pressure control in a population where antihypertensives are given free East Afr Med J 80 529 31 15250626 1:STN:280:DC%2BD2czkslOjuw%3D%3D
50. H Salome Kruger JJ Gerber 1998 Health beliefs and compliance of black South African outpaitents with antihypertensive medication Journal of Social and Administrative Pharmacy 15 201 9
51. LD Saunders LM Irwig JS Gear DL Ramushu 1991 A randomized controlled trial of compliance improving strategies in Soweto hypertensives Med Care 29 669 78 2072772 10.1097/00005650-199107000-00007 1:STN:280:DyaK3MzgsVSqsQ%3D%3D
52. P Sookaneknun RM Richards J Sanguansermsri C Teerasut 2004 Pharmacist involvement in primary care improves hypertensive patient clinical outcomes Ann Pharmacother 38 2023 8 15522983 10.1345/aph.1D605
53. CM Stein P Neill GM Mwaluko T Kusema 1990 Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe S Afr Med J 77 243 5 2107581 1:STN:280:DyaK3c7ptlymug%3D%3D
54. V Supramaniam 1982 Study of Malaysian military hypertensives-therapy compliance Med J Malaysia 37 249 52 7177007 1:STN:280:DyaL3s%2FovVejsQ%3D%3D
55. B Unterhalter 1979 Compliance with Western medical treatment in a group of black ambulatory hospital patients Soc Sci Med [Med Psychol Med Sociol] 13A 621 30 1:STN:280:DyaL3c7kslGrsg%3D%3D
56. H-M Xiao X-Y Jiang 2005 Drug compliance of elderly patients with hypertension Chin J Clin Rehabil 9 30 1
57. RM Youssef II Moubarak 2002 Patterns and determinants of treatment compliance among hypertensive patients East Mediterr Health J 8 579 92 15603041 1:STN:280:DC%2BD2cnislKrsg%3D%3D
58. K Yusuff A Alabi 2007 Assessing patient adherence to anti-hypertensive drug therapy: Can a structured pharmacist-conducted interview separated the wheat from the chaff? International Journal of Pharmacy Practice 15 295 300 10.1211/ijpp.15.4.0007
59. KB Yusuff OB Balogun 2005 Pattern of drug utilization among hypertensives in a Nigerian teaching hospital Pharmacoepidemiol Drug Saf 14 69 74 15508134 10.1002/pds.1035 1:STN:280:DC%2BD2cnjtlWrtg%3D%3D
60. T Zdrojewski W Januszko W Drygas, et al. 1999 Pharmacotherapy of arterial hypertension and pharmacoeconomic aspects of hypotensive therapy in elderly patients in Poland Pol Arch Med Wewn 102 787 95 10949886 1:STN:280: DC%2BD3cvmtVeisg%3D%3D
61. X Jiang W Li L Ma L Kong S Jin L Liu 2002 Knowledge on hypertension and the effect of management on hypertension in patients attending hospital clinics Zhonghua Liu Xing Bing Xue Za Zhi 23 269 72 12411071
62. SA Khalil AG Elzubier 1997 Drug compliance among hypertensive patients in Tabuk, Saudi Arabia J Hypertens 15 561 5 9170010 10.1097/00004872-199715050- 00013 1:STN:280:DyaK2szhtlKjuw%3D%3D
63. D Toprak S Demir 2007 Treatment choices of hypertensive patients in Turkey Behav Med 33 5 10 17517540 10.3200/BMED.33.1.5-10
64. JC Prado Jr E Kupek D Mion Jr 2007 Validity of four indirect methods to measure adherence in primary care hypertensives J Hum Hypertens 21 579 84 17443212
65. HL Venter PH Joubert GN Foukaridis 1991 Compliance in black patients with non-insulin-dependent diabetes mellitus receiving oral hypoglycaemic therapy S Afr Med J 79 549 51 2024212 1:STN:280:DyaK3M3itVagug%3D%3D
66. F Babwah S Baksh L Blake, et al. 2006 The role of gender in compliance and attendance at an outpatient clinic for type 2 diabetes mellitus in Trinidad Rev Panam Salud Publica 19 79 84 16551381 10.1590/S1020-49892006000200002
67. J Cui 2005 Association of educational level and behavior of medical compliance with the level of blood glucose in diabetic patients Chin J Clin Rehabil 2005 36
68. EM Duff A O'Connor N McFarlane-Anderson YB Wint EY Bailey RA Wright-Pascoe 2006 Self-care, compliance and glycaemic control in JAMAican adults with diabetes mellitus West Indian Med J 55 232 6 17249312 10.1590/S0043-31442006000400006 1:STN:280:DC%2BD2s%2Fks1OqtQ%3D%3D
69. BR Duran-Varela B Rivera-Chavira E Franco-Gallegos 2001 Pharmacological therapy compliance in diabetes Salud Publica Mex 43 233 6 11452700 10.1590/S0036-36342001000300009 1:STN:280:DC%2BD3MvgtF2luw%3D%3D
70. M El-Shazly M Abdel-Fattah A Zaki, et al. 2000 Health care for diabetic patients in developing countries: a case from Egypt Public Health 114 276 81 10962591 10.1016/S0033-3506(00)00345-0 1:STN:280:DC%2BD3cvnsVKjsw%3D%3D
71. ME Garay-Sevilla LE Nava JM Malacara, et al. 1995 Adherence to treatment and social support in patients with non-insulin dependent diabetes mellitus J Diabetes Complications 9 81 6 7599352 10.1016/1056-8727(94)00021-F 1:STN:280:DyaK2Mzit1KgsA%3D%3D
72. B Hanko M Kazmer P Kumli, et al. 2007 Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes Pharm World Sci 29 58 66 17187222 10.1007/s11096-006-9070-2
73. L Hernandez-Ronquillo JF Tellez-Zenteno J Garduno-Espinosa E Gonzalez-Acevez 2003 Factors associated with therapy noncompliance in type-2 diabetes patients Salud Publica Mex 45 191 7 12870420 10.1590/S0036- 36342003000300008
74. K Kaur MM Singh Kumar I Walia 1998 Knowledge and self-care practices of diabetics in a resettlement colony of Chandigarh Indian J Med Sci 52 341 7 9988968 1:STN:280:DyaK1M7ktlGisQ%3D%3D
75. MS Khattab MA Aboifotouh MY Khan MA Humaidi YM al-Kaldi 1999 Compliance and control of diabetes in a family practice setting, Saudi Arabia East Mediterr Health J 5 755 65 11338698 1:STN:280:DC%2BD3MzgvFCqsw%3D%3D
76. RB Roaeid AA Kablan 2007 Profile of diabetes health care at Benghazi Diabetes Centre, Libyan Arab JAMAhiriya East Mediterr Health J 13 168 76 17546919 1:STN:280:DC%2BD2szjsFaitg%3D%3D
77. G Srinivas E Suresh M Jagadeesan E Amalraj M Datta 2002 Treatment-seeking behavior and compliance of diabetic patients in a rural area of south India Ann N Y Acad Sci 958 420 4 12021154 10.1111/j.1749-6632.2002.tb03017.x 1:STN:280:DC%2BD38zit1agug%3D%3D
78. M Yousuf M Ali I Bano 2001 Non-compliance of drug therapy in diabetics- Experience at Lahore Pakistan Journal of Medical Sciences 17 74 8
79. CY Zhang S Xie Y Li Z Li 2005 Survey of the drug compliance of type 2 diabetic patients in Chenghai district of Shantou city Chin J Clin Rehabil 9 14 5 1:CAS:528:DC%2BD28Xpt1Oit7w%3D
80. K Bhagat M Mazayi-Mupanemunda 2001 Compliance with medication in patients with heart failure in Zimbabwe East Afr Med J 78 45 8 11320766 1:STN:280:DC%2BD38%2FgvVWmsw%3D%3D
81. PP Joshi CJ Mohanan SP Sengupta RG Salkar 1999 Factors precipitating congestive heart failure-role of patient non-compliance J Assoc Physicians India 47 294 5 10999123 1:STN:280:DC%2BD3cvkslyitQ%3D%3D
82. A Sadik M Yousif JC McElnay 2005 Pharmaceutical care of patients with heart failure Br J Clin Pharmacol 60 183 93 16042672 10.1111/j.1365-2125.2005. 02387.x 1:STN:280:DC%2BD2MzosV2ntg%3D%3D
83. I Moodley 2006 Analysis of a medical aid administrator database for costs and utilisation of benefits by patients claiming for lipid-lowering agents Cardiovasc J S Afr 17 140 5 16807632
84. S Asefzadeh M Asefzadeh H Javadi 2005 Care management: Adherence to therapies among patients at Bu-Alicina Clinic, Qazvin, Iran Journal of Research in Medical Sciences 10 343 8
85. PR Chizzola AJ Mansur PL da Luz G Bellotti 1996 Compliance with pharmacological treatment in outpatients from a Brazilian cardiology referral center Sao Paulo Med J 114 1259 64 9239925 10.1590/S1516-31801996000500004 1:STN:280:DyaK2szosVSkuw%3D%3D
86. RA Dantas OM Aguillar CB dos Santos Barbeira 2002 Implementation of a nurse-monitored protocol in a Brazilian hospital: a pilot study with cardiac surgery patients Patient Educ Couns 46 261 6 11932125 10.1016/S0738-3991(01) 00162-8
87. AM El-Gatit M Haw 2003 Relationship between depression and non-adherence to anticoagulant therapy after valve replacement East Mediterr Health J 9 12 9 15562728 1:STN:280:DC%2BD2crovFahsA%3D%3D
88. A Kocer N Ince E Kocer A Tasci 2006 Factors influencing treatment compliance among Turkish people at risk for stroke J Prim Prev 27 81 9 16421657 10.1007/s10935-005-0020-x
89. JO Olubodun AO Falase TO Cole 1990 Drug compliance in hypertensive Nigerians with and without heart failure Int J Cardiol 27 229 34 2365511 10.1016/0167-5273(90)90164-Z 1:STN:280:DyaK3czgsleguw%3D%3D
90. AP Rotchford KM Rotchford 2002 Diabetes in rural South Africa-an assessment of care and complications S Afr Med J 92 536 41 12197196 1:STN:280:DC%2BD38vjvFGhsQ%3D%3D
91. IC Wiseman R Miller 1991 Quantifying non-compliance in patients receiving digoxin-a pharmacokinetic approach S Afr Med J 79 155 7 1994486 1:STN:280:DyaK3M7jsVOitg%3D%3D
92. M Di Matteo 2004 Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research Med Care 42 200 9 10.1097/01.mlr.0000114908.90348.f9
93. DC Chan WH Shrank D Cutler, et al. 2010 Patient, physician, and payment predictors of statin adherence Med Care 48 196 202 19890219 10.1097/MLR. 0b013e3181c132ad
94. Gaziano 2005 Cardiovascular disease in the developing world and its cost-effective management Circulation 112 3547 53 16330695 10.1161/ CIRCULATIONAHA.105.591792
95. SH Woolf RE Johnson 2005 The break-even point: when medical advances are less important than improving the fidelity with which they are delivered Ann Fam Med 3 545 52 16338919 10.1370/afm.406
96. CA Green 1987 What can patient health education coordinators learn from ten years of compliance research? Patient Education & Counseling 10 167 74 10.1016/0738-3991(87)90096-6 1:STN:280:DyaL1c%2FmvVWhtg%3D%3D
97. AS Kesselheim NK Choudhry 2008 The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients Ann Intern Med 148 614 9 18413623
98. EJ Mills JB Nachega D Bangsberg 2006 Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-reported Barriers and Facilitators PLoS Med 3 e438 17121449 10.1371/journal.pmed.0030438
99. NK Choudhry MA Fischer J Avorn, et al. 2011 The implications of therapeutic complexity on adherence to cardiovascular medications Arch Intern Med 171 814 22 21555659 10.1001/archinternmed.2010.495
100. NK Choudhry 2011 Promoting persistence: improving adherence through choice of drug class Circulation 123 1584 6 21464048 10.1161/CIRCULATIONAHA.111. 024471